Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePoster: MM-186: HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD): Subgroup Analysis.AuthorsRichardson, Paul G.; Mateos, María-Victoria; Oriol, Albert; Larocca, Alessandra; Cavo, Michele; Rodríguez-Otero, Paula; Leleu, Xavier; Norkin, Maxim; Nadeem, Omar; Hiemenz, John W; Hassoun, Hani; Touzeau, Cyrille; Alegre, Adrián; Paner, Agner; Maisel, Christopher; Mazumder, Amitabha; Raptis, Anastasios; Puig, Noemí; Zamagni, Elena; Thuresson, MarcusPublicationClinical Lymphoma, Myeloma & Leukemia, 2021, Vol 21, pS250ISSN2152-2650Publication typeArticleDOI10.1016/S2152-2650(21)01573-1